orphenadrine and pk 11195

orphenadrine has been researched along with pk 11195 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E	1

Other Studies

1 other study(ies) available for orphenadrine and pk 11195

Article	Year
Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. British journal of pharmacology, 2001, Volume: 132, Issue:3 Topics: Animals; Antihypertensive Agents; Blotting, Western; Body Weight; Cell Survival; Cerebellum; Corpus Striatum; Disease Models, Animal; Drug Interactions; Isoquinolines; Male; Mortality; Muscarinic Antagonists; Neurotoxicity Syndromes; Nitro Compounds; Orphenadrine; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tritium	2001

Article

Year

Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

British journal of pharmacology, 2001, Volume: 132, Issue:3

Topics: Animals; Antihypertensive Agents; Blotting, Western; Body Weight; Cell Survival; Cerebellum; Corpus Striatum; Disease Models, Animal; Drug Interactions; Isoquinolines; Male; Mortality; Muscarinic Antagonists; Neurotoxicity Syndromes; Nitro Compounds; Orphenadrine; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tritium

2001